Role of inhibitory κB kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetes

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 301, Issue 3, 2011, Pages

  Jiang, Shaoning ^a   Messina, Joseph L ^a,b  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Injury; Insulin signaling; Liver; Serine kinase

Indexed keywords

ADENOVIRUS VECTOR; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; STRESS ACTIVATED PROTEIN KINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DIABETES MELLITUS; DISEASE COURSE; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CRITICAL ILLNESS; DIABETES MELLITUS, TYPE 2; ENZYME ACTIVATION; HEMORRHAGE; I-KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 80052294383     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00148.2011     Document Type: Article

References (59)

1. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J Biol Chem 275: 9047-9054, 2000.
2. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531-1537, 2002.
3. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85: 3770-3778, 2000.
4. Altavilla D, Saitta A, Squadrito G, Galeano M, Venuti SF, Guarini S, Bazzani C, Bertolini A, Caputi AP, Squadrito F. Evidence for a role of nuclear factor-κB in acute hypovolemic hemorrhagic shock. Surgery 131: 50-58, 2002.
5. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198, 2005.
6. Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 58: 921-924, 2005.
7. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11: 183-190, 2005.
8. Cree MG, Wolfe RR. Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab 294: E1-E9, 2008.
9. Dajani R, Sanlioglu S, Zhang Y, Li Q, Monick MM, Lazartigues E, Eggleston T, Davisson RL, Hunninghake GW, Engelhardt JF. Pleiotropic functions of TNF-α determine distinct IKKβ-dependent hepatocellular fates in response to LPS. Am J Physiol Gastrointest Liver Physiol 292: G242-G252, 2007.
10. Faingold MC, Benzadon MN, Musso C, Dinardo V, Navia D, Sinay IR. Hyperglycemia at admission to a surgical intensive care unit is a risk factor for later development of DM2. In: Abstracts of the 70th Scientific Sessions of the American Dietetic Association. Chicago, IL: Am. Diet. Assoc., 2010.
11. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Hypoglycemia with intensive insulin therapy. A systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 94: 729-740, 2008.
12. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297, 2009.
13. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. Serine phosphorylation of insulin receptor substrate 1 by inhibitor-κB kinase complex. J Biol Chem 277: 48115-48121, 2002.
14. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 51: 540-544, 2001.
15. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 18: 2195-2224, 2004.
16. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336, 2002.
17. Hotamisligil GS. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 245: 621-625, 1999.
18. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in tumor necrosis factor-α- and obesity-induced insulin resistance. Science 271: 665-668, 1996.
19. Jiang S, Gavrikova TA, Pereboev A, Messina JL. Adenovirus infection results in alterations of insulin signaling and glucose homeostasis. Am J Physiol Endocrinol Metab 298: E1295-E1304, 2010.
20. Kim PK, Deutschman CS. Inflammatory responses and mediators. Surg Clin North Am 80: 885-894, 2000.
21. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 35: 2262-2267, 2007.
22. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 56: 1058-1062, 2004.
23. Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab 20: 429-435, 2009.
24. Li L, Thompson LH, Zhao L, Messina JL. Tissue specific difference in the molecular mechanisms for the development of acute insulin resistance following injury. Endocrinology 150: 24-32, 2009.
25. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, Lin A. NF-κB is required for UV-induced JNK activation via induction of PKCκ. Mol Cell 21: 467-480, 2006.
26. Liu J, Yang H, Liu W, Cao X, Feng X. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor-κB ligand gene in osteoblasts and bone marrow stromal cells. J Cell Biochem 96: 716-727, 2005.
27. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH, Messina JL. Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-α. Endocrinology 145: 5168-5176, 2004.
28. Ma Y, Wang P, Kuebler JF, Chaudry IH, Messina JL. Hemorrhage induces the rapid development of hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 284: G107-G115, 2003.
29. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 17: 107-124, 2001.
30. Miller-Jensen K, Janes KA, Wong YL, Griffith LG, Lauffenburger DA. Adenoviral vector saturates Akt pro-survival signaling and blocks insulin-mediated rescue of tumor necrosis-factor-induced apoptosis. J Cell Sci 119: 3788-3798, 2006.
31. Mollen KP, McCloskey CA, Tanaka H, Prince JM, Levy RM, Zuckerbraun BS, Billiar TR. Hypoxia activates c-Jun N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes. Shock 28: 270-277, 2007.
32. Munoz MC, Giani JF, Mayer MA, Toblli JE, Turyn D, Dominici FP. TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. J Endocrinol 201: 185-197, 2009.
33. Muruve DA, Barnes MJ, Stillman IE, Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil- dependent hepatic injury in vivo. Hum Gene Ther 10: 965-976, 1999.
34. Nakamori Y, Emoto M, Fukuda N, Taguchi A, Okuya S, Tajiri M, Miyagishi M, Taira K, Wada Y, Tanizawa Y. Myosin motor Myo1c and its receptor NEMO/IKK-γ promote TNF-α-induced serine 307 phosphorylation of IRS-1. J Cell Biol 173: 665-671, 2006.
35. Nakatani Y, Kaneto H, Kawamori D, Hatazaki M, Miyatsuka T, Matsuoka TA, Kajimoto Y, Matsuhisa M, Yamasaki Y, Hori M. Modulation of the JNK pathway in liver affects insulin resistance status. J Biol Chem 279: 45803-45809, 2004.
36. Perkins ND. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
37. Rohl M, Pasparakis M, Baudler S, Baumgartl J, Gautam D, Huth M, De Lorenzi R, Krone W, Rajewsky K, Bruning JC. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J Clin Invest 113: 474-481, 2004.
38. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
39. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 22: 674-682, 2005.
40. Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q, Shen HM, Whiteman M, Huang C. IKKβ programs to turn on the GADD45α-MKK4-JNK apoptotic cascade specifically via p50 NF-κB in arsenite response. J Cell Biol 175: 607-617, 2006.
41. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96, 2006.
42. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358, 2003.
43. Thompson LH, Kim HT, Ma Y, Kokorina N, Messina JL. Acute muscle-type specific insulin resistance following injury. Mol Med 11-12: 715-723, 2008.
44. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 2: 69-78, 1999.
45. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87: 978-982, 2002.
46. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van WE, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 354: 449-461, 2006.
47. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367, 2001.
48. Vriesendorp TM, DeVries JH, Hoekstra JB. Hypoglycemia and strict glycemic control in critically ill patients. Curr Opin Crit Care 14: 397-402, 2008.
49. Walsh KB, Toledo AH, Rivera-Chavez FA, Lopez-Neblina F, Toledo- Pereyra LH. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant 7: 78-93, 2009.
50. Winkelman C. Inactivity and inflammation: selected cytokines as biologic mediators in muscle dysfunction during critical illness. AACN Clin Issues 15: 74-82, 2004.
51. Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-κB and JNK activation in hepatocytes. Biochem Pharmacol 72: 1090-1101, 2006.
52. Xu J, Kim HT, Ma Y, Zhao L, Zhai L, Kokorina N, Wang P, Messina JL. Trauma and hemorrhage-induced acute hepatic insulin resistance: dominant role of tumor necrosis factor (TNF)-α. Endocrinology 149: 2369-2382, 2008.
53. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 55: 33-38, 2003.
54. Youngren JF. Regulation of insulin receptor function. Cell Mol Life Sci 64: 873-891, 2007.
55. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ. Science 293: 1673-1677, 2001.
56. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243- 252, 1997.
57. Zhai L, Ballinger SW, Messina JL. Role of reactive oxygen species in injury-induced insulin resistance. Mol Endocrinol 25: 492-502, 2011.
58. Zick Y. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol 11: 437-441, 2001.
59. Zick Y. Uncoupling insulin signalling by serine/threonine phosphorylation: a molecular basis for insulin resistance. Biochem Soc Trans 32: 812-816, 2004.